Due to the COVID-19 pandemic, the global Transdermal Patch market size is estimated to be worth USD 7058.3 million in 2022 and is forecast to a readjusted size of USD 8726.9 million by 2028 with a CAGR of 3.6% during the review period.
Fully considering the economic change by this health crisis, Methyl Salicylate-based Patch accounting for % of the Transdermal Patch global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Rx Channel segment is altered to an % CAGR throughout this forecast period.
Key drivers of the transdermal patch market include the growing painless and non-invasive medicinal therapies for chronic diseases such as Parkinson’s, Alzheimer’s, migraine, joint, muscle pain, etc.
The technological developments in drug delivery systems will further propel the transdermal patch market growth in the coming years.
The increasing awareness regarding the harmful effects of tobacco and smoking will accelerate the market expansion during the review period.
However, Skin irritation, infection and permeability concerns will restrict the market in the upcoming years. The inability of the skin to absorb a large number of medications is expected to create hurdles moving ahead.
What is Transdermal Patch?
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal patches are gaining widespread acceptance over oral medications. The benefits include smooth and faster drug delivery through non-invasive means. The easy availability, visual cue, hassle-free administration, and limited drug interaction boost its widescale usage in the medical industry, especially amongst the geriatric population. Moreover, methyl salicylate-based patches make the skin feel cool and warm simultaneously distracting the patient from the actual pain of muscle or joints. Hence these patches are being developed for a variety of chronic diseases which in turn will spur the growth of the transdermal patch market in the upcoming years.
Widespread product innovations have come out in the form of gels, spray, and patches with adhesive layers. Procedures such as thermal ablation, microneedles, and novel systems for drug delivery are being developed. For example, thermal ablation is a system through which skin permeability is achieved in a non-invasive way by removing the stratum corneum or the outermost epidermal layer of the skin. These attractive developments will augment the transdermal patch market growth during the review period.
Smoking is a global healthcare burden. It leads to a variety of diseases such as oral cancer, heart disease, stroke, lung infection, chronic obstructive pulmonary disorder( COPD) and rheumatoid arthritis, etc. Moreover, tobacco kills around 8 million people every year. Hence people are quitting smoking for improving their quality of life. Nicotine-based patches are used for decreasing the withdrawal symptoms caused due to sudden stoppage of cigarette smoking. This will drive the growth of the transdermal patch market in the future.
Transdermal skin patches are ineffective as skin is a strong barrier to outer elements. The molecules small enough are able to penetrate and mix into the bloodstream of patients. Moreover, there are complications such as skin irritation, infection in the case of people with sensitive skin. Hence these factors will hamper the acceleration of the transdermal patch market in subsequent years.
Based on type, the methyl salicylate-based patches will grow the highest in the transdermal patch market share with 18% followed by Lidocaine with 15%.
Based on application, the Rx channel will provide lucrative opportunities for growth in the transdermal patch market share with 76% penetration.
Based on region, North America is expected to maintain dominance in the transdermal patch market share due to rapid R&D initiatives and the rising geriatric population who will benefit from the painless administration of medicinal drugs.
Competitive Landscape and Transdermal Patch Market Insights
Transdermal Patch market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Transdermal Patch product introduction, recent developments, Transdermal Patch sales by region, type, application and by sales channel.
Transdermal Patch market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.
|
Report Metric |
Details |
|
Base Year: |
2021 |
|
Market Size in 2022: |
USD 7058.3 Million |
|
Forecast Period: |
2022 to 2028 |
|
Forecast Period 2021 to 2027 CAGR: |
3.6% |
|
2028 Value Projection: |
USD 8726.9 Million |
|
No. of Pages: |
119 |
|
Tables & Figures |
164 |
|
Segments covered: |
Type, Application, Region |
Ans. The forecast period in the Transdermal Patch Market report is from 2022 to 2028.
Ans. Methyl Salicylate-based segment is a major contributor to the growth of the Transdermal Patch market.
Ans. The Global Transdermal Patch Market size is projected to reach USD 8726.9 Million by 2028 with a CAGR of 3.6% during the forecast period.
1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Patch Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Patch Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Sales Estimates and Forecasts 2017-2028
2.2 Global Transdermal Patch Revenue Estimates and Forecasts 2017-2028
2.3 Global Transdermal Patch Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Transdermal Patch Sales by Region
2.4.1 Global Transdermal Patch Sales by Region (2017-2022)
2.4.2 Global Sales Transdermal Patch by Region (2023-2028)
2.5 Global Transdermal Patch Revenue by Region
2.5.1 Global Transdermal Patch Revenue by Region (2017-2022)
2.5.2 Global Transdermal Patch Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Transdermal Patch Sales by Manufacturers
3.1.1 Global Top Transdermal Patch Manufacturers by Sales (2017-2022)
3.1.2 Global Transdermal Patch Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Transdermal Patch in 2021
3.2 Global Transdermal Patch Revenue by Manufacturers
3.2.1 Global Transdermal Patch Revenue by Manufacturers (2017-2022)
3.2.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Transdermal Patch Revenue in 2021
3.3 Global Transdermal Patch Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Transdermal Patch Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Transdermal Patch Sales by Type
4.1.1 Global Transdermal Patch Historical Sales by Type (2017-2022)
4.1.2 Global Transdermal Patch Forecasted Sales by Type (2023-2028)
4.1.3 Global Transdermal Patch Sales Market Share by Type (2017-2028)
4.2 Global Transdermal Patch Revenue by Type
4.2.1 Global Transdermal Patch Historical Revenue by Type (2017-2022)
4.2.2 Global Transdermal Patch Forecasted Revenue by Type (2023-2028)
4.2.3 Global Transdermal Patch Revenue Market Share by Type (2017-2028)
4.3 Global Transdermal Patch Price by Type
4.3.1 Global Transdermal Patch Price by Type (2017-2022)
4.3.2 Global Transdermal Patch Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Transdermal Patch Sales by Application
5.1.1 Global Transdermal Patch Historical Sales by Application (2017-2022)
5.1.2 Global Transdermal Patch Forecasted Sales by Application (2023-2028)
5.1.3 Global Transdermal Patch Sales Market Share by Application (2017-2028)
5.2 Global Transdermal Patch Revenue by Application
5.2.1 Global Transdermal Patch Historical Revenue by Application (2017-2022)
5.2.2 Global Transdermal Patch Forecasted Revenue by Application (2023-2028)
5.2.3 Global Transdermal Patch Revenue Market Share by Application (2017-2028)
5.3 Global Transdermal Patch Price by Application
5.3.1 Global Transdermal Patch Price by Application (2017-2022)
5.3.2 Global Transdermal Patch Price Forecast by Application (2023-2028)
6 North America
6.1 North America Transdermal Patch Market Size by Type
6.1.1 North America Transdermal Patch Sales by Type (2017-2028)
6.1.2 North America Transdermal Patch Revenue by Type (2017-2028)
6.2 North America Transdermal Patch Market Size by Application
6.2.1 North America Transdermal Patch Sales by Application (2017-2028)
6.2.2 North America Transdermal Patch Revenue by Application (2017-2028)
6.3 North America Transdermal Patch Market Size by Country
6.3.1 North America Transdermal Patch Sales by Country (2017-2028)
6.3.2 North America Transdermal Patch Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Transdermal Patch Market Size by Type
7.1.1 Europe Transdermal Patch Sales by Type (2017-2028)
7.1.2 Europe Transdermal Patch Revenue by Type (2017-2028)
7.2 Europe Transdermal Patch Market Size by Application
7.2.1 Europe Transdermal Patch Sales by Application (2017-2028)
7.2.2 Europe Transdermal Patch Revenue by Application (2017-2028)
7.3 Europe Transdermal Patch Market Size by Country
7.3.1 Europe Transdermal Patch Sales by Country (2017-2028)
7.3.2 Europe Transdermal Patch Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Transdermal Patch Market Size by Type
8.1.1 Asia Pacific Transdermal Patch Sales by Type (2017-2028)
8.1.2 Asia Pacific Transdermal Patch Revenue by Type (2017-2028)
8.2 Asia Pacific Transdermal Patch Market Size by Application
8.2.1 Asia Pacific Transdermal Patch Sales by Application (2017-2028)
8.2.2 Asia Pacific Transdermal Patch Revenue by Application (2017-2028)
8.3 Asia Pacific Transdermal Patch Market Size by Region
8.3.1 Asia Pacific Transdermal Patch Sales by Region (2017-2028)
8.3.2 Asia Pacific Transdermal Patch Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Transdermal Patch Market Size by Type
9.1.1 Latin America Transdermal Patch Sales by Type (2017-2028)
9.1.2 Latin America Transdermal Patch Revenue by Type (2017-2028)
9.2 Latin America Transdermal Patch Market Size by Application
9.2.1 Latin America Transdermal Patch Sales by Application (2017-2028)
9.2.2 Latin America Transdermal Patch Revenue by Application (2017-2028)
9.3 Latin America Transdermal Patch Market Size by Country
9.3.1 Latin America Transdermal Patch Sales by Country (2017-2028)
9.3.2 Latin America Transdermal Patch Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Transdermal Patch Market Size by Type
10.1.1 Middle East and Africa Transdermal Patch Sales by Type (2017-2028)
10.1.2 Middle East and Africa Transdermal Patch Revenue by Type (2017-2028)
10.2 Middle East and Africa Transdermal Patch Market Size by Application
10.2.1 Middle East and Africa Transdermal Patch Sales by Application (2017-2028)
10.2.2 Middle East and Africa Transdermal Patch Revenue by Application (2017-2028)
10.3 Middle East and Africa Transdermal Patch Market Size by Country
10.3.1 Middle East and Africa Transdermal Patch Sales by Country (2017-2028)
10.3.2 Middle East and Africa Transdermal Patch Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Corporation Information
11.1.2 Hisamitsu Pharmaceutical Overview
11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hisamitsu Pharmaceutical Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 UCB Pharma
11.4.1 UCB Pharma Corporation Information
11.4.2 UCB Pharma Overview
11.4.3 UCB Pharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 UCB Pharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 UCB Pharma Recent Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Overview
11.5.3 Mylan Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mylan Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mylan Recent Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Overview
11.6.3 Teva Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Recent Developments
11.7 Nitto Denko
11.7.1 Nitto Denko Corporation Information
11.7.2 Nitto Denko Overview
11.7.3 Nitto Denko Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Nitto Denko Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nitto Denko Recent Developments
11.8 Grünenthal
11.8.1 Grünenthal Corporation Information
11.8.2 Grünenthal Overview
11.8.3 Grünenthal Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Grünenthal Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Grünenthal Recent Developments
11.9 IBSA Group
11.9.1 IBSA Group Corporation Information
11.9.2 IBSA Group Overview
11.9.3 IBSA Group Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 IBSA Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 IBSA Group Recent Developments
11.10 GSK
11.10.1 GSK Corporation Information
11.10.2 GSK Overview
11.10.3 GSK Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 GSK Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GSK Recent Developments
11.11 Luye Pharma Group
11.11.1 Luye Pharma Group Corporation Information
11.11.2 Luye Pharma Group Overview
11.11.3 Luye Pharma Group Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Luye Pharma Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Luye Pharma Group Recent Developments
11.12 Pfizer
11.12.1 Pfizer Corporation Information
11.12.2 Pfizer Overview
11.12.3 Pfizer Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Pfizer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Pfizer Recent Developments
11.13 Chattem
11.13.1 Chattem Corporation Information
11.13.2 Chattem Overview
11.13.3 Chattem Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Chattem Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Chattem Recent Developments
11.14 Dr Reddy’s Laboratories
11.14.1 Dr Reddy’s Laboratories Corporation Information
11.14.2 Dr Reddy’s Laboratories Overview
11.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Dr Reddy’s Laboratories Recent Developments
11.15 Bayer
11.15.1 Bayer Corporation Information
11.15.2 Bayer Overview
11.15.3 Bayer Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Bayer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Bayer Recent Developments
11.16 Mundipharma
11.16.1 Mundipharma Corporation Information
11.16.2 Mundipharma Overview
11.16.3 Mundipharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Mundipharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Mundipharma Recent Developments
11.17 Endo International
11.17.1 Endo International Corporation Information
11.17.2 Endo International Overview
11.17.3 Endo International Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Endo International Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Endo International Recent Developments
11.18 Beijing Tide Pharmaceutical
11.18.1 Beijing Tide Pharmaceutical Corporation Information
11.18.2 Beijing Tide Pharmaceutical Overview
11.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Beijing Tide Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Transdermal Patch Industry Chain Analysis
12.2 Transdermal Patch Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Transdermal Patch Production Mode & Process
12.4 Transdermal Patch Sales and Marketing
12.4.1 Transdermal Patch Sales Channels
12.4.2 Transdermal Patch Distributors
12.5 Transdermal Patch Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Transdermal Patch Industry Trends
13.2 Transdermal Patch Market Drivers
13.3 Transdermal Patch Market Challenges
13.4 Transdermal Patch Market Restraints
14 Key Findings in The Global Transdermal Patch Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Transdermal Patch Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Methyl Salicylate-based Patch
Table 3. Major Manufacturers of Rivastigmine Transdermal Patch
Table 4. Major Manufacturers of Fentanyl Transdermal Patch
Table 5. Major Manufacturers of Lidocaine Patch
Table 6. Major Manufacturers of Diclofenac Patch
Table 7. Major Manufacturers of Nicotine Transdermal Patch
Table 8. Major Manufacturers of Others
Table 9. Global Transdermal Patch Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Transdermal Patch Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Transdermal Patch Sales by Region (2017-2022) & (M Pcs)
Table 12. Global Transdermal Patch Sales Market Share by Region (2017-2022)
Table 13. Global Transdermal Patch Sales by Region (2023-2028) & (M Pcs)
Table 14. Global Transdermal Patch Sales Market Share by Region (2023-2028)
Table 15. Global Transdermal Patch Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Transdermal Patch Revenue Market Share by Region (2017-2022)
Table 17. Global Transdermal Patch Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Transdermal Patch Revenue Market Share by Region (2023-2028)
Table 19. Global Transdermal Patch Sales by Manufacturers (2017-2022) & (M Pcs)
Table 20. Global Transdermal Patch Sales Share by Manufacturers (2017-2022)
Table 21. Global Transdermal Patch Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Transdermal Patch Revenue Share by Manufacturers (2017-2022)
Table 23. Transdermal Patch Price by Manufacturers (2017-2022) &(USD/Pc)
Table 24. Global Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2021)
Table 26. Transdermal Patch Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Transdermal Patch Product Offered
Table 28. Date of Manufacturers Enter into Transdermal Patch Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
Table 31. Global Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
Table 32. Global Transdermal Patch Sales Share by Type (2017-2022)
Table 33. Global Transdermal Patch Sales Share by Type (2023-2028)
Table 34. Global Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Transdermal Patch Revenue Share by Type (2017-2022)
Table 37. Global Transdermal Patch Revenue Share by Type (2023-2028)
Table 38. Transdermal Patch Price by Type (2017-2022) & (USD/Pc)
Table 39. Global Transdermal Patch Price Forecast by Type (2023-2028) & (USD/Pc)
Table 40. Global Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
Table 41. Global Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
Table 42. Global Transdermal Patch Sales Share by Application (2017-2022)
Table 43. Global Transdermal Patch Sales Share by Application (2023-2028)
Table 44. Global Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Transdermal Patch Revenue Share by Application (2017-2022)
Table 47. Global Transdermal Patch Revenue Share by Application (2023-2028)
Table 48. Transdermal Patch Price by Application (2017-2022) & (USD/Pc)
Table 49. Global Transdermal Patch Price Forecast by Application (2023-2028) & (USD/Pc)
Table 50. North America Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
Table 51. North America Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
Table 52. North America Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
Table 55. North America Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
Table 56. North America Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
Table 59. North America Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
Table 60. North America Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
Table 63. Europe Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
Table 64. Europe Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
Table 67. Europe Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
Table 68. Europe Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
Table 71. Europe Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
Table 72. Europe Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
Table 75. Asia Pacific Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
Table 76. Asia Pacific Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
Table 79. Asia Pacific Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
Table 80. Asia Pacific Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Transdermal Patch Sales by Region (2017-2022) & (M Pcs)
Table 83. Asia Pacific Transdermal Patch Sales by Region (2023-2028) & (M Pcs)
Table 84. Asia Pacific Transdermal Patch Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Transdermal Patch Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
Table 87. Latin America Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
Table 88. Latin America Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
Table 91. Latin America Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
Table 92. Latin America Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
Table 95. Latin America Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
Table 96. Latin America Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Transdermal Patch Sales by Type (2017-2022) & (M Pcs)
Table 99. Middle East and Africa Transdermal Patch Sales by Type (2023-2028) & (M Pcs)
Table 100. Middle East and Africa Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Transdermal Patch Sales by Application (2017-2022) & (M Pcs)
Table 103. Middle East and Africa Transdermal Patch Sales by Application (2023-2028) & (M Pcs)
Table 104. Middle East and Africa Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Transdermal Patch Sales by Country (2017-2022) & (M Pcs)
Table 107. Middle East and Africa Transdermal Patch Sales by Country (2023-2028) & (M Pcs)
Table 108. Middle East and Africa Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)
Table 110. Hisamitsu Pharmaceutical Corporation Information
Table 111. Hisamitsu Pharmaceutical Description and Major Businesses
Table 112. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 113. Hisamitsu Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Hisamitsu Pharmaceutical Recent Developments
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Major Businesses
Table 117. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 118. Johnson & Johnson Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Johnson & Johnson Recent Developments
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Major Businesses
Table 122. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 123. Novartis Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Novartis Recent Developments
Table 125. UCB Pharma Corporation Information
Table 126. UCB Pharma Description and Major Businesses
Table 127. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 128. UCB Pharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. UCB Pharma Recent Developments
Table 130. Mylan Corporation Information
Table 131. Mylan Description and Major Businesses
Table 132. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 133. Mylan Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Mylan Recent Developments
Table 135. Teva Pharmaceutical Corporation Information
Table 136. Teva Pharmaceutical Description and Major Businesses
Table 137. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 138. Teva Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Teva Pharmaceutical Recent Developments
Table 140. Nitto Denko Corporation Information
Table 141. Nitto Denko Description and Major Businesses
Table 142. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 143. Nitto Denko Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Nitto Denko Recent Developments
Table 145. Grünenthal Corporation Information
Table 146. Grünenthal Description and Major Businesses
Table 147. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 148. Grünenthal Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Grünenthal Recent Developments
Table 150. IBSA Group Corporation Information
Table 151. IBSA Group Description and Major Businesses
Table 152. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 153. IBSA Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. IBSA Group Recent Developments
Table 155. GSK Corporation Information
Table 156. GSK Description and Major Businesses
Table 157. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 158. GSK Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. GSK Recent Developments
Table 160. Luye Pharma Group Corporation Information
Table 161. Luye Pharma Group Description and Major Businesses
Table 162. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 163. Luye Pharma Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Luye Pharma Group Recent Developments
Table 165. Pfizer Corporation Information
Table 166. Pfizer Description and Major Businesses
Table 167. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 168. Pfizer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Pfizer Recent Developments
Table 170. Chattem Corporation Information
Table 171. Chattem Description and Major Businesses
Table 172. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 173. Chattem Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Chattem Recent Developments
Table 175. Dr Reddy’s Laboratories Corporation Information
Table 176. Dr Reddy’s Laboratories Description and Major Businesses
Table 177. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 178. Dr Reddy’s Laboratories Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Dr Reddy’s Laboratories Recent Developments
Table 180. Bayer Corporation Information
Table 181. Bayer Description and Major Businesses
Table 182. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 183. Bayer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Bayer Recent Developments
Table 185. Mundipharma Corporation Information
Table 186. Mundipharma Description and Major Businesses
Table 187. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 188. Mundipharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Mundipharma Recent Developments
Table 190. Endo International Corporation Information
Table 191. Endo International Description and Major Businesses
Table 192. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 193. Endo International Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Endo International Recent Developments
Table 195. Beijing Tide Pharmaceutical Corporation Information
Table 196. Beijing Tide Pharmaceutical Description and Major Businesses
Table 197. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)
Table 198. Beijing Tide Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Beijing Tide Pharmaceutical Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Transdermal Patch Distributors List
Table 203. Transdermal Patch Customers List
Table 204. Transdermal Patch Market Trends
Table 205. Transdermal Patch Market Drivers
Table 206. Transdermal Patch Market Challenges
Table 207. Transdermal Patch Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Patch Product Picture
Figure 3. Global Transdermal Patch Market Share by Type in 2021 & 2028
Figure 3. Methyl Salicylate-based Patch Product Picture
Figure 4. Rivastigmine Transdermal Patch Product Picture
Figure 5. Fentanyl Transdermal Patch Product Picture
Figure 6. Lidocaine Patch Product Picture
Figure 7. Diclofenac Patch Product Picture
Figure 8. Nicotine Transdermal Patch Product Picture
Figure 9. Others Product Picture
Figure 10. Global Transdermal Patch Market Share by Application in 2021 & 2028
Figure 11. Rx Channel
Figure 12. OTC Channel
Figure 13. Transdermal Patch Report Years Considered
Figure 14. Global Transdermal Patch Sales 2017-2028 (M Pcs)
Figure 15. Global Transdermal Patch Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Transdermal Patch Revenue 2017-2028 (US$ Million)
Figure 17. Global Transdermal Patch Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Transdermal Patch Sales Market Share by Region (2017-2022)
Figure 19. Global Transdermal Patch Sales Market Share by Region (2023-2028)
Figure 20. North America Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
Figure 21. North America Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
Figure 23. Europe Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
Figure 25. Asia-Pacific Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
Figure 27. Latin America Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Transdermal Patch Sales YoY (2017-2028) & (M Pcs)
Figure 29. Middle East & Africa Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Transdermal Patch Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Transdermal Patch in the World: Market Share by Transdermal Patch Revenue in 2021
Figure 32. Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Transdermal Patch Sales Market Share by Type (2017-2028)
Figure 34. Global Transdermal Patch Revenue Market Share by Type (2017-2028)
Figure 35. Global Transdermal Patch Sales Market Share by Application (2017-2028)
Figure 36. Global Transdermal Patch Revenue Market Share by Application (2017-2028)
Figure 37. North America Transdermal Patch Sales Market Share by Type (2017-2028)
Figure 38. North America Transdermal Patch Revenue Market Share by Type (2017-2028)
Figure 39. North America Transdermal Patch Sales Market Share by Application (2017-2028)
Figure 40. North America Transdermal Patch Revenue Market Share by Application (2017-2028)
Figure 41. North America Transdermal Patch Sales Share by Country (2017-2028)
Figure 42. North America Transdermal Patch Revenue Share by Country (2017-2028)
Figure 43. U.S. Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Transdermal Patch Sales Market Share by Type (2017-2028)
Figure 46. Europe Transdermal Patch Revenue Market Share by Type (2017-2028)
Figure 47. Europe Transdermal Patch Sales Market Share by Application (2017-2028)
Figure 48. Europe Transdermal Patch Revenue Market Share by Application (2017-2028)
Figure 49. Europe Transdermal Patch Sales Share by Country (2017-2028)
Figure 50. Europe Transdermal Patch Revenue Share by Country (2017-2028)
Figure 51. Germany Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 52. France Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Transdermal Patch Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Transdermal Patch Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Transdermal Patch Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Transdermal Patch Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Transdermal Patch Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Transdermal Patch Revenue Share by Region (2017-2028)
Figure 62. China Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 65. India Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 67. China Taiwan Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Transdermal Patch Sales Market Share by Type (2017-2028)
Figure 72. Latin America Transdermal Patch Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Transdermal Patch Sales Market Share by Application (2017-2028)
Figure 74. Latin America Transdermal Patch Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Transdermal Patch Sales Share by Country (2017-2028)
Figure 76. Latin America Transdermal Patch Revenue Share by Country (2017-2028)
Figure 77. Mexico Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Transdermal Patch Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Transdermal Patch Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Transdermal Patch Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Transdermal Patch Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Transdermal Patch Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Transdermal Patch Revenue Share by Country (2017-2028)
Figure 86. Turkey Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Transdermal Patch Revenue (2017-2028) & (US$ Million)
Figure 89. Transdermal Patch Value Chain
Figure 90. Transdermal Patch Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
$4900
$7850
$9800
HAVE A QUERY?
OUR CUSTOMER
SIMILAR REPORTS